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Objectives The integration of community pharmacy 
services (CPSs) into primary care practice can be 
enhanced by assessing (and further addressing) the 
elements that enable (ie, facilitators) or hinder (ie, 
barriers) the implementation of such CPSs. These 
elements have been widely researched from the 
perspective of pharmacists but not from the perspectives 
of other stakeholders who can interact with and influence 
the implementation of CPSs. The aim of this study 
was to synthesise the literature on patients’, general 
practitioners’ (GPs) and nurses’ perspectives of CPSs to 
identify barriers and facilitators to their implementation in 
Australia.
Methods A meta-synthesis of qualitative studies was 
performed. A systematic search in PubMed, Scopus and 
Informit was conducted to identify studies that explored 
patients’, GPs’ or nurses’ views about CPSs in Australia. 
Thematic synthesis was performed to identify elements 
influencing CPS implementation, which were further 
classified using an ecological approach.
results Twenty-nine articles were included in the review, 
addressing 63 elements influencing CPS implementation. 
Elements were identified as a barrier, facilitator or both 
and were related to four ecological levels: individual 
patient (n=14), interpersonal (n=24), organisational (n=16) 
and community and healthcare system (n=9). It was 
found that patients, nurses and GPs identified elements 
reported in previous pharmacist-informed studies, such as 
pharmacist’s training/education or financial remuneration, 
but also new elements, such as patients’ capability to 
follow service's procedures, the relationships between GP 
and pharmacy professional bodies or the availability of 
multidisciplinary training/education.
Conclusions Patients, GPs and nurses can describe a 
large number of elements influencing CPS implementation. 
These elements can be combined with previous findings in 
pharmacists-informed studies to produce a comprehensive 
framework to assess barriers and facilitators to CPS 
implementation. This framework can be used by pharmacy 
service planners and policy makers to improve the analysis 
of the contexts in which CPSs are implemented.
IntrOduCtIOn
The implementation of new health interven-
tions and services into established healthcare 
practices and systems has been found to be 
challenging.1–4 The inherent complexity of 
both health services and healthcare systems 
may be fundamental to the implementation 
problem.5 6 According to current health 
planning approaches, the implementation 
strengths and limitations of this study
 ► The particular method chosen for this review (ie, 
qualitative meta-synthesis) is aimed at synthesising 
qualitative literature and so enabled a rich 
description of the barriers and facilitators perceived 
by GPs, patients and nurses who can influence the 
implementation of CPSs in Australia.
 ► A systematic search was conducted in three 
comprehensive electronic databases (ie, PubMed, 
Scopus and Informit), one of which (ie, Informit) is 
particularly relevant to the specific context where 
the results will be applied.
 ►
 ► A set of quality appraisal criteria was used to 
appraise all the studies included in this review to 
ensure minimal quality.
 ► Qualitative meta-synthesis was conducted by one 
researcher according to a three-stage method for 
thematic synthesis.
 ► This review was restricted to a specific 
implementation context (ie, Australia), to which its 
results are directly relevant and will be immediately 
applied and actions will be taken.
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of health services can be enhanced by comprehensively 
assessing the context in which they will be delivered. 
Analysis of the context should consider the stakeholders 
who can influence or be affected by the health service, 
as well as the social, physical, economic and policy envi-
ronments that can enable or hinder the normalisation 
of the service.2 7 Early identification of these elements 
(including how they relate to or interact with each other) 
is a key step for developing suitable strategies and inter-
ventions to enhance health service implementation.
In the implementation science literature, several terms 
are used to refer to the elements that can influence service 
implementation and practice change. Some generally 
known examples, which are commonly used interchange-
ably in the literature,8 are: barriers and facilitators,9 
determinants of practice,7 implementation factors10 
or constructs.2 The current use of these terms encloses 
different concepts. For the purpose of this review and to 
avoid the terminological debate, we have used the term 
‘influential element’ as a neutral term.
Amid increasing awareness of the uniqueness of the 
community pharmacy setting and the positive contri-
bution pharmacists can make to healthcare,11 there has 
been a shift towards pharmacists providing more profes-
sional, patient-centred services. However, the implemen-
tation and sustainability of community pharmacy services 
(CPSs) and the integration of community pharmacists 
into primary healthcare teams remain a challenge world-
wide.12 13 In consistence with this international trend, 
Australian community pharmacies are eager to provide 
CPSs and receive remuneration from the government for 
its provision but are experiencing challenges in the imple-
mentation, uptake and sustainability of CPSs.14 Extensive 
research has been conducted to identify the elements 
that from the perspective of community pharmacists (ie, 
service provider) can influence the implementation of 
CPSs.14–16 However, considering the view of a single stake-
holder group is insufficient to comprehensively analyse 
the complexity of a particular implementation context. 
These limited analyses can lead to the development of 
inadequate implementation strategies and interven-
tions. Patients, general practitioners (GPs) and primary 
care nurses are key stakeholders who interact with or are 
affected by CPSs and may be able to strongly influence 
the implementation of such services. These stakeholders 
may have their own particular views about CPSs and so 
can complement the findings from previous pharmacy-in-
formed research.14 15 Patients’, nurses’ and GPs’ views 
and experiences regarding CPSs have been explored 
in several qualitative studies,17–21 but no review that 
collates and analyses such information exists. Qualitative 
meta-synthesis aims to synthesise qualitative literature to 
provide a new, more comprehensive interpretation of the 
findings that goes beyond the depth and breadth of the 
original studies and to broaden the range of concepts 
identified.22 23 Thus, the aim of this study was to synthe-
sise such qualitative literature to describe the broad range 
of elements that, from the patients’, GPs’ and nurses’ 
perspectives, can hinder or enable the implementation of 
CPSs in Australia.
MethOds
Search strategy, screening and eligibility criteria
A systematic search was conducted in May 2015 in three 
electronic databases (ie, PubMed, Scopus and Informit), 
without time limits, to identify qualitative studies 
addressing patients’, nurses’ or GPs’ views about CPSs 
in Australia. A CPS was assumed to refer to an action or 
set of actions delivered in or organised by a community 
pharmacy to optimise the process of care, with the aim of 
improving health outcomes and the value of healthcare.24 
For the purpose of this review, CPSs are specific health 
programmes that are implemented in addition to routine 
professional activities performed by community pharma-
cists, which do not require any specific or extra imple-
mentation effort (ie, they are part of normal community 
pharmacy practice). Since medicine dispensing is the 
main routine activity in the community pharmacy, it 
was not considered as a CPS so it was excluded. Articles 
that did not address a specific CPS but interprofessional 
collaboration (ie, between community pharmacists and 
other healthcare professionals) were included as they can 
also provide insight into the elements influencing the 
implementation of CPSs. Full search strategies are avail-
able on online supplementary appendix 1. In addition, 
the references from the included papers were searched 
manually for additional relevant studies. A two-step 
process was performed by one researcher to select studies 
for the analysis. As a first step, titles and abstracts were 
screened to identify and exclude non-relevant literature. 
In the second step, full texts of the remaining articles 
were reviewed to exclude those that: (1) were not related 
to CPSs; (2) did not address patient, nurse and/or GP 
perspective; (3) did not use qualitative research method-
ology25; (4) did not clearly identify the stakeholder (ie, 
patient, nurse or GP) as the source of the information; 
and (5) were not accessible in any of the research team 
university libraries or unattainable following contact with 
the authors.
All the included articles were checked by the same 
researcher for ‘elementary quality assessment’ using the 
first three criteria delineated by Dixon-Woods et al26 to 
appraise qualitative research: (1) was the research ques-
tion clear?; (2) was the research questions suited to qual-
itative inquiry?; and (3) were (A) sampling, (B) data 
collection and (C) analysis clearly described? Articles 
were excluded when no answer, or an unclear answer, was 
given to at least one of the three questions.
synthesis
Qualitative meta-synthesis was conducted by one 
researcher according to the three-stage method for 
thematic synthesis described by Thomas et al.27 The first 
stage of the analysis involved free line-by-line coding of 
the original data (study participants’ quotes) and the 
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study authors’ interpretation of the original data. The 
process of coding involves summarising text from the 
results and discussion sections of each article into one or 
more descriptive issues (ie, codes) to capture meaning. 
The second stage of the process involved grouping codes 
into one or more descriptive themes. Subsequent articles 
were coded into pre-existing themes, and new themes 
were created when considered necessary. To simplify the 
terminology throughout this article, themes were inter-
preted as elements (ie, influential elements) that could 
positively (ie, facilitators) or negatively (ie, barriers) influ-
ence CPS implementation or practice change. A barrier 
was defined as ‘any type of obstacle (material or immaterial) 
which can impede the dissemination, implementation and/or 
sustainability of a CPS’, while a facilitator was defined as 
‘any type of element (material or immaterial) which can help to 
overcome barriers and/or accelerate the dissemination or imple-
mentation’ of a CPS.16 Themes that were related to similar 
issues were further grouped to create one broad barrier 
or facilitator. The identified influential elements were 
reviewed by a second researcher to assess clarity, consis-
tency and understanding. At the third stage, barriers 
and facilitators were organised using an adapted version 
of the Ecological Model (table 1),28 which classified 
them into four different levels: patient, interpersonal, 
organisational and community/system. The four levels 
defined in table 1 were used as an overarching structure, 
with further subheadings created during analysis, for 
appropriate allocation and organisation of the influen-
tial elements into the levels. The ecological model has 
been widely and successfully used for planning services 
in a variety of settings, targeting different populations 
and problems.29 30 Coding of papers that were identified 
manually was conducted last. NVivo V.10 software (QSR 
International Pty; Doncaster, Victoria, Australia) was used 
to help manage and analyse the data. Once all the influen-
tial elements were identified, a second round of analysis 
was conducted to identify where a connection or rela-
tionship was mentioned between two or more elements. 
Again, both study participants’ quotes and study authors’ 
data interpretation were reviewed for this purpose. A 
network representing the identified relationships was 
generated using a ForceAtlas2 layout31 with Gephi V.0.8. 
This article has been written following existing guidelines 
for reporting the synthesis of qualitative research (the 
Enhancing transparency in reporting the synthesis of 
qualitative research: ENTREQ Statement).32
results
The systematic and manual search identified 243 articles 
once duplicates were removed. After title and abstract 
screening, 124 full-text articles were assessed for eligi-
bility of which 29 articles were included in the qualitative 
meta-synthesis (all of them fulfilled the appraisal criteria) 
(figure 1). A description of the papers included in the 
review can be found in table 2. Of the 29 included papers, 
15 addressed patients’ perspectives only, 2 addressed 
nurses’ perspectives only, 6 addressed GPs’ perspectives 
only, 2 addressed nurses’ and GPs’ perspectives together, 3 
addressed patients’ and GPs’ perspectives together and 1 
addressed the views of all three participants. Twenty-three 
articles were related to a specific CPS, two were related 
specifically to interprofessional collaboration, three were 
related to both CPSs and interprofessional collaboration 
and one addressed concordance-based healthcare. The 
articles employed semistructured interviews (n=23) and/
or focus groups (n=11) as methods of data collection.
During the first stage of data extraction, 181 patient, 
30 nurse and 91 GP codes were created. At the comple-
tion of the coding process, 63 influential elements were 
identified (table 3). These elements were found to exist 
as a barrier, facilitator or both. In several studies patients, 
nurses and GPs were able to describe approaches or 
strategies to overcome specific barriers.17–20 33–43 These 
strategies have been reported in table 3 as additional 
facilitators (marked with an asterisk). During coding of 
the manually identified papers, it seemed that conceptual 
Table 1 Levels where elements that can influence the implementation of community pharmacy services can exist (adapted 
from McLeroy et al28)
Individual 
patient
Influential elements related to the personal characteristics and ideas concerning individual patients (ie, 
individual determinants), such as their knowledge, beliefs and skills, that can affect their utilisation of 
community pharmacy services.
Interpersonal Influential elements related to the healthcare providers and non-healthcare personnel (ie, individual 
determinants) who are involved with the community pharmacy service and with whom patients associate (eg, 
family, friends, pharmacists, pharmacy assistants, GPs and nurses) and the formal and informal relationships 
between patients and healthcare professionals and healthcare professionals with other healthcare 
professionals.
Organisational Influential elements related to characteristics of the community pharmacy setting and their decision 




Influential elements related to the larger society (ie, environmental determinants), which consists of 
collectives of people in a geographical location, the relationships between organisations, the political players 
in the system and the rules, regulations and policies that have the power to control and/or influence the 
implementation of services.
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saturation may have been reached, since no new barriers 
or facilitators were identified.
Individual patient level
All the 16 elements at the patient level were identified 
by patients. GPs and nurses did not identify any addi-
tional patient-related barriers and facilitators. Influential 
elements at this level were related to the patients’ needs, 
preferences, perceptions and expectations, capabilities 
or previous experiences with community pharmacists and 
services. Patients’ health-related concerns, understanding 
or perception of their health problems are important 
elements that influence patients’ need for healthcare and 
so their decisions to use CPSs. Most patients held posi-
tive views about CPSs and the role of the pharmacist in 
providing such services.38 40 44 Some articles highlighted 
that positive experiences were related to the patient 
feeling comfortable and welcomed in the pharmacy.44–46 
When CPSs required a formal referral from the GP, some 
patients deterred from requesting the services. These 
patients perceived that by requesting a CPS they would be 
bothering the GP36 or offending and compromising their 
relationship with the GP.18 40 47Patients also reported that 
having a negative experience with a CPS also deterred 
them from accessing and using such CPSs in the future.46
Interpersonal level
Influential elements at the interpersonal level were related 
to two categories or sublevels: (1) individual healthcare 
professionals (which also includes professional pharmacy 
staff) and (2) relationships (or interactions) between indi-
viduals (which includes both the relationships between 
healthcare professionals and between those professionals 
and patients).
Individual healthcare professionals
Seven elements were identified and related to charac-
teristics of the community pharmacists (n=4), nurses 
(n=4) and GPs (n=4) and characteristics of non-provider 
personnel (ie, other community pharmacy staff members, 
eg, pharmacy assistant) (n=5). Articles reported that GPs’ 
and nurses’ service support varied depending on their 
perceptions or understanding of CPSs and the role of 
pharmacists. Home medicine review services had a great 
deal of approval and support from the GP perspective.40 42 
On the other side, pharmacists providing immunisations 
raised some conflicting views among GPs since they 
believed this was the role of the GP or nurse practitioner.42 
Some studies highlighted that GPs had a limited under-
standing of the capabilities of the pharmacist as service 
providers with pharmacists perceived as drug sellers 
in a retail environment.34–36 48 49 Both patients and GPs 
implied the need for pharmacists to undergo upskilling 
and training to be qualified to provide some CPSs.34 37 47
Relationships (or interactions) between individuals
Articles reported that well-established relationships 
between the pharmacist and the nurse or the GP, 
Figure 1 PRISMA flow diagram. PRISMA, Preferred Reporting Items for Systematic Review and Meta-Analysis.
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Table 3 Elements that can hinder (ie, barrier) or enable (ie, facilitator) the implementation of CPSs as identified by patients, 
general practitioners and nurses
Effect on implementation and source of 
information (ie, stakeholder)
Barrier* Facilitator†
Elements at the individual patient level
1. Patients’ real or perceived need for healthcare (according to patients’ 
individual concerns, understanding or perception of their health problems).
Pt18 40 49 51 53; GP17 Pt18 33 35 36 38 43 47 49 51; N41; 
GP17
2. Patients’ awareness of the availability of CPS Pt33 40 47; GP20 40
3. Patient personal desire or preference for CPSs Pt38 47 49 51
4. Patients’ understanding, perceptions and expectations of their own role in 
the CPS
Pt36 49 70 Pt17 36 49
5. Patients’ understanding, perceptions and expectations of the role of 
community pharmacists in healthcare
Pt17 18 35 36 38 46 49; 
N41; GP20
Pt35 38 45 46 49 67 70
6. Patients’ understanding, perceptions and expectations of the role of the GP 
associated to the CPS
Pt35 36 40 47 49 51 69 70
7. Patients’ understanding, perceptions and expectations of collaboration 
between healthcare professionals
Pt49 Pt49
8. Patients’ availability, time to participate in CPSs Pt33 44 Pt44 49
9. Patients’ previous/background experiences with CPSs and multidisciplinary 
care
Pt38 40 46 49 Pt40 45 46 49 51 69
10. Patient abilities; that is, to follow the procedures of the CPS or to self-
manage their health problems
Pt44 49; GP36 42 50 Pt44 47 67
11. Patients’ satisfaction with the delivered CPSs and multidisciplinary care Pt36 44–46 51; N41
12. Patients’ motivation towards CPSs Pt51 Pt44 51 67
13. Patients’ level of emotional intelligence; that is, ability to cope with 
negative experiences.
Pt44 Pt44
14. Patients’ language, communication and cultural issues Pt47 52; GP20
Elements at interpersonal level
a. Individual healthcare professionals (sublevel)
a.1. Community pharmacist
15. Knowledge, expertise, clinical and non-clinical skills (eg, cultural 
competency) to adequately provide CPSs
Pt46; GP34 42 Pt18*, 20, 38, 40, 41*, 42, 44, 48; 
GP37 50
16. Communication skills, including the capacity to speak other languages Pt47 69; N68 Pt18 33 35 38 47 67 69 70
17. Humanistic attributes (eg, being respectful, caring, non-judgemental, 
friendly, empathetic, supportive and approachable)
Pt44 Pt33 35 36 38 39 44–46 49 51
18. Willingness, interest and motivation to provide CPSs and/or participate in 
multidisciplinary collaboration
N33 41 49 67; GP40 Pt35
a.2. Other community pharmacy staff members (eg, pharmacy assistants)
19. Technical knowledge (eg, about a product) Pt38 46 Pt38
20. Communication skills Pt46 Pt38
21. Humanistic attributes Pt38
22. Ability to work professionally (eg, uphold patient confidentiality) Pt39 46
23. Experience working in the pharmacy Pt38 46 Pt38
a.3. GP
24. Understanding, perceptions and expectations of their individual role with 
regard CPSs
GP42 50
25. Understanding, perceptions and expectations of pharmacist’s capabilities 
and role in healthcare
GP34 36 42 48 50 GP17 34 36 37 43 50
26. Awareness of the availability of CPS GP20
27. Willingness, interest, motivation to collaborate with CPSs GP20 GP20 50
Continued
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28. Understanding, perceptions and expectations of their individual role 
within, or in regards to, CPSs
N19
29. Knowledge and skills to adequately participate in the delivery of CPS N19 N19*
30. Attitude towards other healthcare professionals and their roles N19
31. Willingness, interest and motivation to collaborate with CPSs N19 N19
b. Relationships (or interactions) between individuals (sublevel)
32. Influence of friends and family on patients utilising CPSs (ie, they may 
provide support, affect patient’s adherence or patient’s enthusiasm with 
CPSs)
Pt38 44 47 Pt17*, 35*, 41
33. Previous relationship between the patient and the pharmacist and its 
nature (eg, trusting relationship)
Pt18; GP20 Pt18 33 36 38 44–46 51; GP42
34. Collaborative relationships between the pharmacist and other healthcare 
providers (eg, GPs) and their nature
Pt43; N41; 
GP34 40 42 43 48 68
Pt35 49; N19 41; GP17*, 20, 52-
54, 57
35. Communication channels and modes between pharmacists and other 
healthcare providers (eg, GPs)
N19 68; GP36 42 50 53 Pt17 18 35; N41; GP17 42 48 50
36. Existence of referral mechanisms between healthcare professionals, 
including also those between pharmacy support staff and pharmacists (ie, 
care coordination and transition)
Pt46; GP36 42; N,41 Pt38 45; GP17 20 36 37 40 42 50; 
N41
37. Consistency in the information provided by the pharmacist with regards to 
the GP’s recommendations
GP42 43 48 68 GP42 43
38. Availability of multidisciplinary education, training and meetings for 
pharmacists and GPs that enhance integrated, collaborative care
Pt52*, 56*; N41; GP17 34 42 48
Elements at the organisational level
a. Community pharmacy setting (sublevel)
39. Accessibility of the pharmacy setting (eg, convenient location, colocation, 
no appointments required and opening hours)
Pt17 69; N41 Pt17, 33, 35, 37, 38, 40, 41, 56*, 57; 
N41; GP47*, 52*, 53
40. Structural characteristics of the pharmacy setting, that is, size, provision 
of counselling rooms, use of visual space for posters and child-friendly area
Pt39 Pt40, 41, 43*
41. Privacy of the setting, including the availability of a private consultation 
area and limited involvement of multiple staff members who would be aware 
of the patients’ personal matters
Pt18 38 39 46 49 69; 
GP20; N68
Pt39 44 45
42. Availability of suitable material resources to support the service (eg, 
educational material for patients, medical devices, patient data management 
system and so on)
Pt38 46 52
43. Sufficient qualified staff to perform CPS Pt52; GP20 40 43 Pt47
44. Organisation of the pharmacist’s workload and time to deliver CPSs Pt38 47 49 69; N41; 
GP33 40
Pt38 43
45. Organisational commitment to implement a CPS Pt33 38; N41
46. Promotion of the CPS to facilitate its uptake Pt33*, 35*, 47; GP20
b. CPS
47. Extent to which the CPS meets and is tailored to fit individual patient’s 
needs or fills existing gaps in healthcare practice (this enhances the value of 
the service for patients and healthcare professionals)
Pt18 35 36 40 46 49 51; 
GP42 50
Pt18 33 35 38 40 45–47 49 51 69; 
N40; GP20 37 40 42 43 48 50 53
48. Quality of the CPS (eg, validity, accuracy of the materials and tools used, 
CPSs provided in a timely manner, provision of both verbal and written 
information, professional advice and education and so on)
Pt51; GP40 43; N19 Pt18 38 44 45; GP20
49. Complexity of the CPS for use by healthcare professionals GP20; N19 41
Table 3 Continued 
Continued
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including collaborative relationships, were essential 
for the success of a CPS.17 19 20 35 41 50 Multidisciplinary 
education and training for healthcare professionals was 
suggested as a way to improve healthcare professional 
competence.49 Similarly, characteristics of the relation-
ship between the patient and the pharmacist (eg, trust) 
was a key element that influenced pharmacy choice, 
contributed to the patient adhering to the CPS, and 
accepting the intervention.18 33 36 38 44–46 51 Some articles 
reported the influence of family and friends on patient 
utilisation of CPSs (eg, providing support and influ-
encing motivation),35 49 and others commented on the 
integration of partners into the CPS (eg, provision of 
group sessions with partners).35 45
Organisational level
Also at the organisational level, influential elements were 
divided into two sublevels: (1) the community pharmacy 
setting (n=8) and (2) the service itself (n=8).
The community pharmacy setting
Some articles identified the accessibility of the pharmacy 
facilitated interprofessional relationships between GPs 
and pharmacists42 48 and influenced patient17 38 45 and 
nurse41 participation in CPS. In some articles, non-En-
glish speaking patients reported that the lack of multilin-
gual staff limited their awareness and access to CPSs.47 52 
Other articles noted GP and nurse concerns regarding 
the lack of pharmacies that provide CPSs41 and insuffi-
cient accredited pharmacists to perform CPSs.40 43
The community pharmacy service
Concerns regarding the validity and accuracy of the tools 
and instruments used (eg, medical devices and medica-
tion charts) were raised by GPs and nurses.19 42Patients and 
nurses commented that having the same service provider 
at each encounter facilitated rapport building between 
the patient and the pharmacist38 45 51 and caused fewer 
errors when it came to preparing dose administration 
aids.19 Furthermore, patients, nurses and GPs reported 
Effect on implementation and source of 
information (ie, stakeholder)
Barrier* Facilitator†
50. Extent to which CPSs provide ongoing support, follow-up and feedback 
to patients
GP42 Pt18 33 39 40 44–46
51. Flexibility to use different communication channels (eg, telephone and 
website) to interact with patients and healthcare providers
Pt38, 40, 43*
52. Consistency in the community pharmacist delivering the CPS Pt,38 45 51 N19*
53. Involvement of other healthcare providers in delivering the CPS Pt38; N19*; GP20*
54. Costs and duration of the CPS consultation for the patient Pt43 49; N41 Pt43 45; GP17 20; N51*,
Elements at the community and health system level
55. General consumer education about healthcare; promotion of CPS by the 
media
Pt43; GP43 Pt43 47; GP47*, 57
56. Collaboration, influences, conflicts between GP and pharmacist 
professional bodies
GP34*
57. Organisation of GPs’ workload and time to collaborate with CPSs GP20 40 42 50 53
58. Complexity of system-level administrative processes (eg, tedious 
paperwork) associated to the delivery of CPS; that is, complying with the 
requirements of the department of health
GP17 20 40 43 48
59. Availability of an electronic system for sharing information Pt18 49 Pt17*, 57; N19*; GP17, 20*, 36*, 
50, 52*, 53
60. Presence of agreed healthcare protocols, regulations, rules and policies to 
facilitate the delivery of CPSs
Pt52; N41 Pt52; GP20*, 52, 53
61. Limits on the healthcare budget; that is, funding allocated to support CPS 
delivery
GP17 40 43 50 Pt44, 56*; GP17 42 43
62. Availability of financial incentives for service provision and inter-
professional collaboration
Pt56*; N51*
63. Organisation of the healthcare system Pt49; GP43
*Barrier: the element was mentioned to act as a BARRIER or hinder to the implementation of CPSs.
†Facilitator: the element was mentioned to act as a FACILITATOR or enabler to the implementation of CPSs.
(*) This element was reported as a potential strategy to overcome a barrier (ie, facilitator).
CPSs, community pharmacy services; GP, general practitioner; N, nurse; Pt, patient.
Table 3 Continued 
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on the involvement/participation of healthcare profes-
sionals other than pharmacists in the provision of CPSs,38 
or to act as a point of liaison,20 to improve the quality and 
efficiency of the service. The cost of the service was a key 
element, mentioned by all stakeholders, that could either 
discourage41 49 or motivate45 patients to use services. In 
particular, it was mentioned that smaller, manageable cost 
payments for patients could facilitate CPS use.41
Community and healthcare system level
Nine influential elements were identified at this level. 
Several articles identified the need for adequate remu-
neration for GPs and pharmacists for participating in 
and providing CPSs17 42 50 52 as well as the implementation 
of an electronic system of information sharing between 
these two healthcare professionals.19 20 36 43 GPs also 
cited the availability of competing, government-funded 
health programmes and their high level of workload 
and lack of time as contributing to their low participa-
tion in CPSs.40 Where services were available, remuner-
ated and widely supported by GPs and patients, such as 
home medicine reviews (ie, a medication review service), 
GPs mentioned complex bureaucratic procedures (eg, 
completing tedious documents) may discourage their 
use.17 20 40 43 48 Despite this, the home medicine review 
service was generally considered successful by GPs and a 
frequently reported reason for this was the presence of 
a clear protocol guiding service delivery.20 42 48 GPs also 
suggested increased and improved collaboration between 
pharmacy and GP professional representative bodies may 
improve awareness of the services and encourage partic-
ipation. The media was perceived to have an important 
role in improving awareness of and promoting CPSs. 
Finally, some broad comments suggesting some addi-
tional issues at the higher levels of the healthcare system 
were mentioned, such as ‘better and more responsible 
organisation of the healthcare system’.43
With regards to the interactions between the iden-
tified influential elements, 12 articles out of 29 
mentioned some form of a relationship between certain 
elements.20 33 41 42 44 46–48 50 51 53 54 As shown in online supple-
mentary appendix 2, a total of 27 relationships between 25 
elements were found, with 10 elements presenting two or 
more relationships with others (two elements showed five 
or more interactions). As a result of the limited, unsystem-
atic information reported in the articles, a sparse network 
disclosing the recognised relationships between elements 
was obtained (see online supplementary appendix 2).
dIsCussIOn
To the best of our knowledge, this is the first review that 
summarises comprehensive information on the elements 
that, according to patients, nurses and GPs, can enable 
or hinder the implementation of CPSs. Patients, GPs 
and nurses are key members of the primary healthcare 
team and their support and expectations for CPSs can 
highly influence their implementation.1 19 42 54–57 Thus, 
by synthesising and organising the influential elements 
identified by these key stakeholders, this review can opti-
mise future analyses of barriers and facilitators to the 
implementation of CPSs and so potentially enhance their 
integration into primary practice. Importantly, this work 
was intentionally restricted to a specific implementation 
context (ie, Australia), to which its results are directly 
relevant and will be immediately applied. Focusing only 
on Australia is not considered a limitation of the study, 
rather it is a sensible decision that allows knowledge about 
a particular context of interest to be gained. Including 
studies conducted in contexts or healthcare systems other 
than Australia (eg, UK, USA and so on), where barriers 
and facilitators to CPS implementation can be dissimilar 
in nature and expressed differently, may have brought 
irrelevant or inappropriate information to this anal-
ysis, and so hinder the understanding of the context of 
interest. However, it should be noted that Australia is a 
country with a large experience in CPS implementation 
and where significant research has been conducted in 
this regard compared with other countries worldwide. 
Therefore, it is expected that the comprehensive list of 
influential elements identified in this context may be 
relevant to start investigating barriers and facilitators to 
CPS implementation in countries with less experience. 
Furthermore, the elements identified in this review can 
provide insight to pharmacy service planners in other 
countries to guess and avoid some problems in the imple-
mentation of CPSs beforehand.
Barriers and facilitators to the implementation of CPSs 
in Australia have been well researched and reported from 
the perspective of community pharmacists.14 15 56 58 In this 
regard, the results of this review confirms that patients, 
nurses and GPs also recognise some of the influential 
elements reported in previous pharmacist-informed 
studies, such as the pharmacist’s education and training, 
collaboration between the pharmacist and the GP, acces-
sibility of the pharmacy setting and financial remunera-
tion. However, this study provides additional insight into 
further barriers and facilitators, across different ecolog-
ical levels, that are relevant to other key stakeholders 
and so are less likely to be reported by pharmacists, for 
example, patients’ capability to follow the procedures 
of the service, GPs’ workload, nurses’ attitudes towards 
other healthcare professionals/services, the actual rela-
tionships between GP and pharmacy professional bodies 
or the availability of multidisciplinary training and educa-
tion. These results highlight the importance of engaging 
key stakeholders other than pharmacists to better under-
stand the contexts in which CPSs are implemented. In 
other words, disregarding the input of these stakeholders 
(or considering only the views of pharmacists) may lead 
to an incomplete and biased understanding of the imple-
mentation context which, in turn, can result in service 
underutilisation, unsuccessful implementation and 
limited service impact.59 Generally, involving relevant 
stakeholders throughout the development, implemen-
tation and evaluation of health programmes is crucial 
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to increase the chances of any of those initiatives being 
effective and successfully implemented.6 29 30 60 Indeed, 
this is equally relevant to CPS planning.61 62
Semistructured interviews and/or focus group with 
healthcare professionals and patients appear to be appro-
priate methods to identify a large number of unique influ-
ential elements.63 Thus, pharmacy service planners can 
continue to use these methods to identify determinants 
of pharmacy practice in their own context. Although, the 
type of qualitative method used may affect the type of 
barriers/facilitators identified, it is more likely that the 
aims of the studies included in this review, their target 
population and/or the specific service/topic addressed 
by the study may have had a stronger influence in the type 
of barriers or facilitator identified.
The results of this review can assist pharmacy service 
planners and researchers to better identify the elements 
that may be enabling or hindering the implementation 
of existing CPSs. By combining the list of influential 
elements generated in this review with previous findings 
in pharmacists-informed studies, a comprehensive frame-
work to assess barriers and facilitators to CPS implemen-
tation can be produced. Assessing and understanding 
the elements influencing pharmacy practice and service 
implementation must be a key early step in developing 
appropriate, multilevel programmes (ie, including inter-
ventions targeting elements at different levels) aimed 
at enhancing the integration of CPSs into the health-
care system.29 30 62 64 Also, influential elements should be 
prompted and assessed when designing new CPSs. Iden-
tifying elements prior to designing a new CPS may guide 
both the early adaptation of the service to the context, 
as well as the early development of tailored implemen-
tation programmes to better fit (or change) the imple-
mentation context. As an analysis of influential elements 
is likely to yield a large number of items, it would not be 
feasible to address each and every one of those elements. 
Thus, once elements have been identified for a specific 
context, further efforts are required to prioritise those 
elements that are most relevant and can be practically 
addressed.8 65 In this regard, McMillan et al66 provide a 
summary of methods used to determine priorities and 
how they have been used in pharmacy practice research, 
which can guide pharmacy service planners in this regard.
The analysis conducted in this review revealed three 
concerns that must be considered to improve future 
studies aimed at identifying influential elements. On the 
one hand, some influential elements at the community 
and healthcare system level were too broadly described 
(ie, ‘organisation of the health system’) and further 
exploration is needed to clearly understand the specific 
‘items’ that they encompass. Presumably, the list of 
determinants of practice described by Flottorp et al7 (ie, 
Tailored Implementation in Chronic Disease checklist) 
can provide more detail regarding influential elements 
at the higher community and healthcare system level 
and so can initially assist to better frame future anal-
ysis of barriers and facilitators to CPS implementation. 
Particularly, the determinants under the domains ‘Incen-
tives and resources’, ‘Capacity for organisational change’ 
and ‘Social political and legal factors’ seem particularly 
relevant for this purpose. Importantly, to bring further 
insight on the elements at the community and healthcare 
system level, it would be important to include and explore 
the perspectives of other potential key stakeholders, such 
as other healthcare providers (eg, specialists), caregivers, 
representatives of healthcare organisations and profes-
sional bodies, policy makers and so on. Furthermore, 
future studies aimed at identifying barriers and facilitators 
to CPS implementation must better describe and under-
stand the relationships between elements.2 7 This may 
help to understand how elements influence each other 
and which elements are more suitable to be addressed 
(based on the overall effect that they can produce on 
other elements) when designing implementation efforts.
limitations
The network analysis intended in this study was strongly 
constrained by the limited and unsystematically reported 
information about the relationships between influen-
tial elements. As a result, it was decided not to report 
further results of the network analysis beyond its picto-
rial representation. The potential of a full network anal-
ysis should be considered in future studies aimed at 
analysing elements that influence the implementation 
of CPSs. A suitable network analysis can help to better 
understand the complex relationships between these 
elements, detect the core elements that may primarily 
explain the implementation challenge and provide 
insight on the key leverage points that should be targeted 
within the network to enhance service implementation. 
Ideally, accurate information on relevant attributes of 
the influential elements (and the interactions between 
them) should be collected by the authors of the primary 
studies to increase the potential of a network analysis, for 
example, the frequency of occurrence, the direction of 
the relationships, the domain or level where the element 
is located (ie, patients, healthcare professionals, profes-
sional interactions and so on), the relative relevance of 
each element or the effect on implementation outcomes 
(ie, performance as barrier or facilitator).
Following the particular method chosen for this 
review (ie, qualitative meta-synthesis),22 23 only primary 
research articles that used qualitative methods were 
included. Meta-synthesis enabled a rich description 
of elements perceived by GPs, patients and nurses to 
influence implementation of CPSs in Australia. Future 
reviews that synthesise the quantitative literature on this 
topic are encouraged. Appraising qualitative research is 
controversial because of the difficulty of using informa-
tion about quality to inform syntheses (eg, even studies 
with flaws in methodology can provide valuable infor-
mation).26 Furthermore, there is no gold standard on 
appraising qualitative studies.32 The elementary quality 
assessment conducted in the current review was aimed 
at ensuring minimal quality while identifying a broad 
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range of elements that might influence CPS implemen-
tation. Lastly, the papers included in this review were not 
restricted by the time at which they were published, since 
the aim of the study was to include all relevant papers that 
can inform about any influential element that has been 
noted in practice. It is important to acknowledge that as 
contexts can change over time, the effect of influential 
elements can also change, cease to exist or new elements 
can emerge. It is therefore important to regularly monitor 
elements and prioritise those that must be addressed.
COnClusIOn
This qualitative meta-synthesis identified a broad range 
of elements that, according to patients, GPs and nurses, 
can enable (ie, facilitators) or hinder (ie, barriers) the 
implementation of CPSs. These influential elements 
are located at different ecological levels and should be 
considered together with those previously identified in 
pharmacy-informed studies to comprehensively analyse 
the barriers and facilitators to the implementation of 
CPSs. Future studies aimed at that purpose must involve 
multiple stakeholder groups (ie, others than only phar-
macists) and better understand the relationships between 
influential elements to increase the usefulness and 
interest of their findings. Further to the identification of 
the influential elements, key stakeholders should keep 
involved in developing suitable, multilevel programmes 
aimed at enhancing CPS implementation.
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